Marinus Pharmaceuticals News

Marinus Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer

Jan 2 15:27 ET

Marinus Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer

Dec 30, 2024 07:15 ET

Marinus Pharmaceuticals | 8-K: Current report

Dec 30, 2024 07:15 ET

Marinus Pharmaceuticals | 8-K: Current report

Dec 30, 2024 07:05 ET

Marinus Pharmaceuticals | 8-K: Current report

Dec 23, 2024 16:08 ET

Marinus Pharmaceuticals | 8-K: Current report

Dec 10, 2024 16:10 ET

Marinus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 10, 2024 15:20 ET

Marinus Pharmaceuticals | 8-K: Current report

Nov 15, 2024 08:04 ET

Marinus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sofinnova Investments, Inc.(8.0%),James Healy(8.0%), etc.

Nov 14, 2024 18:41 ET

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(0%),Bihua Chen(0%)

Nov 14, 2024 15:07 ET

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eventide Asset Management, LLC(0.00%),Finny Kuruvilla, M.D. Ph. D.(0.00%), etc.

Nov 14, 2024 12:26 ET

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Nov 14, 2024 10:38 ET

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)

Nov 14, 2024 09:37 ET

Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 12, 2024 16:46 ET

Marinus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:16 ET

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.08%)

Nov 12, 2024 16:06 ET

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jennison Associates LLC(0%)

Nov 12, 2024 10:00 ET

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.08%)

Nov 4, 2024 13:45 ET

Marinus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Panacea Innovation Limited(9.98%),Panacea Venture Healthcare Fund II, L.P.(9.98%), etc.

Nov 1, 2024 20:32 ET

Marinus Pharmaceuticals | SCHEDULE 13G/A: Others

Oct 31, 2024 13:11 ET